Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

NCT00602459 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

418

Enrollment

NIH

Sponsor class

Conditions

Stage I Chronic Lymphocytic Leukemia
Stage II Chronic Lymphocytic Leukemia
Stage III Chronic Lymphocytic Leukemia
Stage IV Chronic Lymphocytic Leukemia

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
BIOLOGICAL: Rituximab

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]
[object Object]
[object Object]